Position in NBIX
as of Mar 31, 2026
· filed Apr 15, 2026
Position Value
$295,097
+$17,394 QoQ
Shares Held
2,240
+14.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026GF FUND MANAGEMENT CO. LTD. holds $4,201,196 across 31 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (7.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
12,054 | $1,424,903 | |
| 2 | VTRS |
Viatris Inc
|
57,777 | $780,567 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
967 | $573,411 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
14,343 | $297,760 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
This page
|
2,240 | $295,097 | |
| 6 | ALKS |
Alkermes plc.
|
3,709 | $131,150 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
7,060 | $87,755 | |
| 8 | INDV |
Indivior Pharmaceuticals, Inc.
|
2,804 | $85,465 |
All Filings in NBIX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $295,097 | 2,240 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $277,703 | 1,958 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $299,570 | 2,134 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $325,914 | 2,593 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $286,785 | 2,593 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $290,199 | 2,126 | Shares | Sole | 2025-02-19 | |
| No filing history on record for this holder in this stock. | ||||||